Literature DB >> 12507919

Interleukin-3 receptors in Hodgkin's disease.

Herbert Bosshart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12507919      PMCID： PMC1851101          DOI： 10.1016/s0002-9440(10)63827-8

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  13 in total

1.  Expression of survival receptors in Hodgkin disease cell lines.

Authors:  Herbert Bosshart
Journal:  Blood       Date:  2002-05-01       Impact factor: 22.113

Review 2.  Growth factors in development, transformation, and tumorigenesis.

Authors:  M Cross; T M Dexter
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

3.  Differentiation of an interleukin 3-dependent precursor B-cell clone into immunoglobulin-producing cells in vitro.

Authors:  T Kinashi; K Inaba; T Tsubata; K Tashiro; R Palacios; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

Review 4.  Hematopoietic regulators: redundancy or subtlety?

Authors:  D Metcalf
Journal:  Blood       Date:  1993-12-15       Impact factor: 22.113

Review 5.  Apoptosis in cancer therapy: crossing the threshold.

Authors:  D E Fisher
Journal:  Cell       Date:  1994-08-26       Impact factor: 41.582

6.  Expression of functional interleukin-3 receptors on Hodgkin and Reed-Sternberg cells.

Authors:  Donatella Aldinucci; Dalisa Poletto; Annunziata Gloghini; Paola Nanni; Massimo Degan; Tiziana Perin; Paola Ceolin; Francesca Maria Rossi; Valter Gattei; Antonino Carbone; Antonio Pinto
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

7.  Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor beta 1 and cancer chemotherapy compounds in myeloid leukemic cells.

Authors:  J Lotem; L Sachs
Journal:  Blood       Date:  1992-10-01       Impact factor: 22.113

Review 8.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

Authors:  N L Harris; E S Jaffe; H Stein; P M Banks; J K Chan; M L Cleary; G Delsol; C De Wolf-Peeters; B Falini; K C Gatter
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

9.  Activating point mutations in the common beta subunit of the human GM-CSF, IL-3 and IL-5 receptors suggest the involvement of beta subunit dimerization and cell type-specific molecules in signalling.

Authors:  B J Jenkins; R D'Andrea; T J Gonda
Journal:  EMBO J       Date:  1995-09-01       Impact factor: 11.598

10.  Suppression of apoptotic death in hematopoietic cells by signalling through the IL-3/GM-CSF receptors.

Authors:  T Kinoshita; T Yokota; K Arai; A Miyajima
Journal:  EMBO J       Date:  1995-01-16       Impact factor: 11.598
View more
  1 in total

Review 1.  Belinostat in patients with refractory or relapsed peripheral T-cell lymphoma: a perspective review.

Authors:  Ahmed Sawas; Dejan Radeski; Owen A O'Connor
Journal:  Ther Adv Hematol       Date:  2015-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.